Antimicrobial stewardship programs in adult intensive care units in Latin America: Implementation, assessments, and

Rodolfo E Quirós1, Ana C Bardossy2, Patricia Angeleri3

  • 1Clínica Ángel Foianini, Santa Cruz de la Sierra, Bolivia.

Abstract

Insights

Antimicrobial stewardship programs (ASPs) significantly improved antimicrobial use in Latin American intensive care units. Comprehensive ASPs led to better antimicrobial consumption, adherence, and reduced mortality and infections.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Public Health

Background:

  • Antimicrobial resistance is a growing global health threat.
  • Effective antimicrobial stewardship programs (ASPs) are crucial for optimizing antibiotic use in healthcare settings.
  • Latin America faces unique challenges in implementing and evaluating ASPs in intensive care units (ICUs).

Purpose of the Study:

  • To assess the impact of antimicrobial stewardship programs (ASPs) in adult medical-surgical intensive care units (MS-ICUs) across Latin America.
  • To evaluate the effectiveness of ASPs in improving antimicrobial utilization and patient outcomes.
  • To identify factors associated with successful ASP implementation in resource-limited settings.

Main Methods:

  • A quasi-experimental prospective study with a continuous time series design was conducted over 12 months.
  • Seventy-seven MS-ICUs in 9 Latin American countries participated, including adult patients admitted for at least 24 hours.
  • Antimicrobial stewardship program (ASP) impact was evaluated monthly using antimicrobial consumption, treatment appropriateness, mortality, and multidrug-resistant organism healthcare-associated infections (MDRO-HAIs), alongside self-assessment surveys.

Main Results:

  • MS-ICUs with higher ASP quality scores demonstrated significantly better performance across key indicators.
  • Compared to MS-ICUs in the lowest quartile, those in the highest quartile showed reduced antimicrobial consumption (143.4 vs 159.4 DDD/100 patient-days) and MDRO-HAIs (9.45 vs 10.96 per 1000 patient-days).
  • Improved adherence to clinical guidelines (92.5% vs 59.3%) and pharmacist prescription validation (72.0% vs 58.0%) were observed in high-performing ASPs, alongside lower crude mortality (15.9% vs 17.7%).

Conclusions:

  • Comprehensive antimicrobial stewardship programs (ASPs) are associated with significant improvements in antimicrobial utilization in adult medical-surgical intensive care units (MS-ICUs).
  • Strengthening ASPs can lead to better antimicrobial prescribing, reduced healthcare-associated infections, and improved patient outcomes in Latin American ICUs.
  • The findings underscore the importance of investing in and supporting robust ASPs to combat antimicrobial resistance in critical care settings.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.4K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
714
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
77
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
98
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
106
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
55